Gotowe bibliografie tematyczne / Anticholesteremic agents

Gotowa bibliografia na temat „Anticholesteremic agents”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 3 marca 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Anticholesteremic agents”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Spis treści

  1. Rozprawy doktorskie
  2. Książki

Rozprawy doktorskie na temat "Anticholesteremic agents":

1

Bursill, Christina. "Green tea and its catechins modulate cholesterol metabolism in cultured human liver (HepG2) cells and the hypercholesterolaemic rabbit". Title page, contents and introduction only, 2000. http://web4.library.adelaide.edu.au/theses/09PH/09pdb9725.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Streszczenie:
Includes bibliographical references (21 leaves). Previous studies have found that green tea and its antitoxidant constituents, the catechins, are hypocholesterolaemic in both epidemiological and animal intervetion studies. The main objectives of the present study were to investigate the mechanism by which green tea and its most abundant catechin constituent epigallocatechin gallate increase the low-density lipoprotein (LDL) receptor of HepG2 cells. In addition, it was hoped to determine if a crude catechin extract from green tea could lower plasma cholesterol levels in the hypercholesterolaemic rabbit and ascertain if this effect was due to an increase in the LDL receptor. The study provides evidence that green tea and its catechins exhibit hypocholesterolaemic properties and may therefore provide protection against heart disease.
2

Chen, Jingnan. "Hypocholesterolemic activity of microalga schizochytrium sp". HKBU Institutional Repository, 2012. https://repository.hkbu.edu.hk/etd_ra/1417.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

藍志洪 i Chi-hung Nam. "Effect of cerivastatin on endothelial function in rat aorta". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2001. http://hub.hku.hk/bib/B42575837.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Nam, Chi-hung. "Effect of cerivastatin on endothelial function in rat aorta". Click to view the E-thesis via HKUTO, 2001. http://sunzi.lib.hku.hk/hkuto/record/B42575837.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Marinangeli, Christopher P. F. "The composition, biological trafficking and cholesterol-lowering efficacy of sugarcane-derived policosanol supplements /". Thesis, McGill University, 2006. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=99351.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Streszczenie:
The cholesterol-lowering efficacy of the original sugarcane-derived Cuban policosanol (OPC) supplement has been attributed to an exclusive policosanol purity and composition. The first objective of the following study was to compare the purity and composition of the OPC and alternative sugarcane derived policosanol (APC) products. Second, to measure blood lipids and policosanol levels in tissues, plasma and feces in hamsters receiving diet fortified with no policosanols, OPC, or an APC (APC1) product. Results indicated that the policosanol purity and composition of the OPC and APC formulations are similar. Lipid levels were not significantly different between groups. Policosanols were undetectable in the plasma and tissues of any animals following policosanol supplementation. Policosanols were excreted at a higher rate in animals consuming APC1. Sugarcane-derived policosanols are not an efficacious cholesterol-lowering therapy. The purity and relative percent composition of the OPC supplement cannot account for its efficacy as a lipid lowering agent.
6

Xiu, Jin. "Distribution and function of nicotinic acetylcholine receptors in glia cells and neurons with focus on the neuroprotective mechanisms of cholesterol-lowering drugs in Alzheimer's disease /". Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-758-8/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Eno, Megan. "The effect of the supplementation of cranberry seed oil on the lipid profiles of human subjects". Menomonie, WI : University of Wisconsin--Stout, 2007. http://www.uwstout.edu/lib/thesis/2007/2007enom.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Chapman, Laurie. "In vitro hypocholesterolemic potential of dietary additives used by the Batemi and Maasai people : (Hypocholesterolemic potential of additives from a traditional diet)". Thesis, McGill University, 1994. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=22725.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Streszczenie:
Dietary phytochemicals such as saponins have been suggested to have therapeutic uses in the prevention and alleviation of hypercholesterolemia. Thus, twelve Tanzanian plant additives hypothesized to contain saponins and used in soup by the Batemi, were investigated for in vitro hypocholesterolemic potential by: (1) screening for likelihood of detectable saponins using TLC, hemolysis, frothing ability and molluscicidal activity. (2) using changes in hemolytic activity to indirectly examine interactions of plant extracts with cholesterol, cholesterol-analogues, conjugated bile salts and non-conjugated bile salts. (3) using radiolabelled cholesterol to examine direct binding capacity of extracts with cholesterol. Albizia anthelmintica, Myrsine africana and Acacia goetzii were most likely to contain saponins and had significant (p $<$ 0.05) hemolytic activity that was effected by the presence of cholesterol, cholesterol analogues, conjugated and non-conjugated bile salts (p $<$ 0.05). Methanol, ethyl acetate, aqueous and n-butanol extracts of A. anthelmintica and methanol, ethyl acetate and aqueous extracts of A. goetzii bound significant amounts of cholesterol solubilized in ethanol (p $<$ 0.05). Thus, saponins are a detectable component of the Batemi diet and extracts likely containing saponins do interact with chemicals that have been proposed to be involved in in vivo mechanisms of saponin induced hypocholesterolemia. A. anthelmintica and A. goetzii seem likely to have hypocholesterolemic potential as dietary additives.
9

Tam, Hoi-ling. "Soluble receptors for advanced glycation end products in type 2 diabetes mellitus". Click to view the E-thesis via HKUTO, 2010. http://sunzi.lib.hku.hk/hkuto/record/B43572182.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Boudreau, Denise M. "The association between HMG-CoA inhibitor use and breast cancer risk & a validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use /". Thesis, Connect to this title online; UW restricted, 2002. http://hdl.handle.net/1773/7934.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Anticholesteremic agents” dla poszczególnych typów źródeł:
Rozprawy doktorskie Książki

Książki na temat "Anticholesteremic agents":

1

A, Kramer M., red. Trends in cholesterol research. New York: Nova Biomedical Books, 2005.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

A, Kramer M., red. Cholesterol. Hauppauge, N.Y: Nova Science Publishers, 2005.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Mason, Roger. Lower your cholesterol without drugs: Curing high cholesterol naturally. Wyd. 2. Garden City Park, NY: Square One Publishers, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Mason, Roger. Lower cholesterol without drugs: A practical guide to using diet and supplements for healthy cholesterol levels. Markham, ON: Safe Goods/New Century Pub., 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Steinberg, Daniel. The cholesterol wars: The skeptics vs. the preponderance of evidence. San Diego, Calif: Academic Press, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Steinberg, Daniel. The cholesterol wars: The skeptics vs. the preponderance of evidence. San Diego, Calif: Academic Press, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Steinberg, Daniel. The cholesterol wars: The skeptics vs. the preponderance of evidence. San Diego, Calif: Academic Press, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

1935-, Legato Marianne J., red. Pravastatin sodium--: Over 10 years of experience : a worldwide review of clinical articles from the scientific literature. Montreal: PharmaLibri, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

P, Beck J., Crastes de Paulet A i Institut national de la santé et de la recherche médicale (France), red. Activités biologiques des oxystérols: Séminaire de recherche INSERM, Mittelwihr, 7-9 octobre 1987. Paris: Editions INSERM, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Gaw, Allan. Statins in General Practice: Pocketbook. London: Taylor & Francis, A Martin Dunitz Book, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Do bibliografii